Comparison of Oxygen Delivery Devices for Reversal of Altitude-Induced Hypoxemia in Normal Subjects
NCT ID: NCT01477450
Last Updated: 2014-09-26
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
30 participants
INTERVENTIONAL
2011-10-31
2012-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Continuous Positive Airway Pressure on Peripheral Oxygen Saturation, Work of Breathing, and Exercise Tolerance at Altitude
NCT05971290
Strategy to Avoid Excessive Oxygen for Critically Ill Trauma Patients
NCT04534959
Ability of Caregivers to Provide Ventilation With the SAVe Resuscitator in a Model
NCT01477710
Aviation Portable Oxygen Delivery System
NCT03425409
Oxygen Savings With Administered Oxygen and High Flow Ambient Air At Rest
NCT04170062
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The oxygen requirement to return oxygen saturation to baseline values will be recorded. The flow from the concentrator and the cylinder will be compared.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1 L/min ; 16 mL
Cylinder oxygen delivery (1 L/min) followed by pulse-dose oxygen by concentrator (16 mL)
Pulse-dose oxygen
Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery
Oxygen delivery from an oxygen cylinder
2 L/min ; 32 mL
Cylinder oxygen delivery (2 L/min) followed by pulse-dose oxygen by concentrator (32 mL)
Pulse-dose oxygen
Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery
Oxygen delivery from an oxygen cylinder
3 L/min ; 48 mL
Cylinder oxygen delivery (3 L/min) followed by pulse-dose oxygen by concentrator (48 mL)
Pulse-dose oxygen
Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery
Oxygen delivery from an oxygen cylinder
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Pulse-dose oxygen
Pulsed-dose oxygen delivery from an oxygen concentrator
Cylinder oxygen delivery
Oxygen delivery from an oxygen cylinder
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age 18 years - 60 years
Exclusion Criteria
* Current symptoms of lower respiratory infection -- productive cough
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
United States Air Force
FED
University of Cincinnati
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rich Branson, M.D.
Clinical Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Branson, MSc RRT
Role: PRINCIPAL_INVESTIGATOR
University of Cincinnati
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Brooks City Base
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Branson-2010-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.